| 101 |
20022592 | A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage. | 2010 May 1 |
2 |
| 102 |
20195940 | [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. | 2010 Mar |
1 |
| 103 |
20197647 | Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. | 2010 |
1 |
| 104 |
20236308 | Efficacy and tolerability of rasagiline in daily clinical use--a post-marketing observational study in patients with Parkinson's disease. | 2010 Sep |
1 |
| 105 |
20445015 | Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. | 2010 Dec |
4 |
| 106 |
20517484 | The role of rasagiline in the treatment of Parkinson's disease. | 2010 May 25 |
3 |
| 107 |
20600573 | Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity. | 2010 Nov |
4 |
| 108 |
20624440 | Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells. | 2010 Nov |
1 |
| 109 |
20977789 | [Rasagiline is not for all Parkinson disease patients: the ADAGIO study]. | 2010 |
1 |
| 110 |
20979033 | [Rasagiline: effectiveness and protection in Parkinson's disease]. | 2010 Nov 1 |
1 |
| 111 |
21389939 | [Efficacy of rasagiline in patients with advanced Parkinson's disease with motor fluctuation (azimut study)]. | 2010 |
2 |
| 112 |
23908775 | Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential. | 2010 Jul |
3 |
| 113 |
19110207 | Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs. | 2009 Jan |
1 |
| 114 |
19384601 | Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. | 2009 Apr |
1 |
| 115 |
19526291 | Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. | 2009 Aug |
5 |
| 116 |
19673610 | Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. | 2009 Aug |
1 |
| 117 |
19733607 | Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. | 2009 Nov 13 |
1 |
| 118 |
19753135 | Role of rasagiline in treating Parkinson's disease: Effect on disease progression. | 2009 Aug |
2 |
| 119 |
18067186 | Rasagiline improves freezing in a patient with primary progressive freezing gait. | 2008 Feb 15 |
1 |
| 120 |
18072817 | Spotlight on rasagiline in Parkinson's disease. | 2008 |
4 |
| 121 |
18307054 | [Rasagiline in Parkinson's disease]. | 2008 May |
1 |
| 122 |
18668620 | Medical treatment of freezing of gait. | 2008 |
1 |
| 123 |
18678789 | Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease. | 2008 Sep |
1 |
| 124 |
18833504 | [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. | 2008 Oct |
2 |
| 125 |
18937611 | The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. | 2008 Nov |
2 |
| 126 |
18952510 | Rapid and sensitive liquid chromatography-tandem mass spectrometry: assay development, validation and application to a human pharmacokinetic study. | 2008 Nov 15 |
1 |
| 127 |
19004128 | [The use of a new MAO B inhibitor rasagiline in the treatment of motor fluctuations in Parkinson's disease]. | 2008 |
1 |
| 128 |
17055733 | Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. | 2007 Jan |
2 |
| 129 |
17347320 | The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. | 2007 Jun |
1 |
| 130 |
17495756 | Advances in the pharmacologic management of early Parkinson disease. | 2007 May |
2 |
| 131 |
17545750 | Monamine oxidase inhibitors: current and emerging agents for Parkinson disease. | 2007 May-Jun |
2 |
| 132 |
17630819 | Medical management of levodopa-associated motor complications in patients with Parkinson's disease. | 2007 |
1 |
| 133 |
17635668 | Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. | 2007 Oct |
2 |
| 134 |
17683172 | Rasagiline: a review of its use in the management of Parkinson's disease. | 2007 |
4 |
| 135 |
17702535 | Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors. | 2007 |
1 |
| 136 |
18035186 | Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. | 2007 Sep |
2 |
| 137 |
18041937 | Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. | 2007 Dec |
1 |
| 138 |
18267281 | New strategies in motor parkinsonism. | 2007 |
1 |
| 139 |
18488080 | Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. | 2007 Jun |
3 |
| 140 |
16425668 | Drugs in development for Parkinson's disease: an update. | 2006 Jan |
1 |
| 141 |
16450340 | Rasagiline improves quality of life in patients with early Parkinson's disease. | 2006 May |
1 |
| 142 |
16451296 | Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease. | 2006 Feb |
1 |
| 143 |
16675649 | Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease. | 2006 May 15 |
5 |
| 144 |
16717254 | Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease. | 2006 May 23 |
1 |
| 145 |
16717255 | Clinical trials with rasagiline: evidence for short-term and long-term effects. | 2006 May 23 |
1 |
| 146 |
16828804 | Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. | 2006 Oct 25 |
1 |
| 147 |
16856145 | Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. | 2006 Oct |
2 |
| 148 |
16935943 | A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing. | 2006 Oct |
1 |
| 149 |
17017568 | Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. | 2006 |
1 |
| 150 |
17296539 | Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. | 2006 Dec |
1 |